| Circulating tumor DNA measurements as early outcome predictors in diffuse large B-cell lymphoma DM Kurtz, F Scherer, MC Jin, J Soo, AFM Craig, MS Esfahani, JJ Chabon, ... Journal of Clinical Oncology 36 (28), 2845-2853, 2018 | 403 | 2018 |
| Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA DM Kurtz, J Soo, L Co Ting Keh, S Alig, JJ Chabon, BJ Sworder, A Schultz, ... Nature biotechnology 39 (12), 1537-1547, 2021 | 197 | 2021 |
| Dynamic risk profiling using serial tumor biomarkers for personalized outcome prediction DM Kurtz, MS Esfahani, F Scherer, J Soo, MC Jin, CL Liu, AM Newman, ... Cell 178 (3), 699-713. e19, 2019 | 175 | 2019 |
| Inferring gene expression from cell-free DNA fragmentation profiles MS Esfahani, EG Hamilton, M Mehrmohamadi, BY Nabet, SK Alig, ... Nature biotechnology 40 (4), 585-597, 2022 | 93 | 2022 |
| Short diagnosis-to-treatment interval is associated with higher circulating tumor DNA levels in diffuse large B-cell lymphoma S Alig, CW Macaulay, DM Kurtz, U Dührsen, A Hüttmann, C Schmitz, ... Journal of Clinical Oncology 39 (23), 2605-2616, 2021 | 47 | 2021 |
| Determinants of circulating tumor DNA levels across lymphoma histologic subtypes JG Schroers-Martin, DM Kurtz, J Soo, M Jin, F Scherer, A Craig, ... Blood, The Journal of the American Society of Hematology 130 (Suppl_1), 4018 …, 2017 | 17 | 2017 |
| Tracing founder mutations in circulating and tissue-resident follicular lymphoma precursors JG Schroers-Martin, J Soo, G Brisou, F Scherer, DM Kurtz, BJ Sworder, ... Cancer discovery 13 (6), 1310-1323, 2023 | 12 | 2023 |
| Circulating tumor DNA is a reliable measure of tumor burden at diagnosis of diffuse large B cell lymphoma: an international reproducibility study DM Kurtz, M Jin, J Soo, F Scherer, A Craig, JJ Chabon, ... Blood, The Journal of the American Society of Hematology 130 (Suppl_1), 310-310, 2017 | 10 | 2017 |
| Towards non-invasive classification of DLBCL genetic subtypes by Ctdna profiling MS Esfahani, S Alig, DM Kurtz, J Soo, MC Jin, C Macaulay, AFM Craig, ... Blood 134, 551, 2019 | 9 | 2019 |
| Modified VY fasciocutaneous flap reconstruction after abdominoperineal resection in irradiated patients prevents wound dehiscence and associated complications: a retrospective … G Kokosis, BT Phillips, J Soo, L Poveromo, D Erdmann, CR Mantyh, ... Annals of plastic surgery 82 (2), 218-223, 2019 | 9 | 2019 |
| Development of a dynamic model for personalized risk assessment in large B-cell lymphoma DM Kurtz, F Scherer, M Jin, J Soo, A Craig, MS Esfahani, JJ Chabon, ... Blood, The Journal of the American Society of Hematology 130 (Suppl_1), 826-826, 2017 | 8 | 2017 |
| Phased variant enrichment for enhanced minimal residual disease detection from cell-free DNA DM Kurtz, J Soo, S Alig, LCT Keh, C Macaulay, MC Jin, F Scherer, ... Blood 134, 552, 2019 | 6 | 2019 |
| Comparison of circulating tumor DNA recovery from plasma and serum J Soo, DM Kurtz, M Jin, F Scherer, JG Schroers-Martin, MS Esfahani, ... Blood 130, 2756, 2017 | 6 | 2017 |
| Interim circulating tumor DNA as a prognostic biomarker in the setting of interim PET-based adaptive therapy for DLBCL C Macaulay, S Alig, DM Kurtz, MC Jin, S Opat, J Soo, B Sworder, ... Blood 134, 1600, 2019 | 5 | 2019 |
| Distinct chromatin accessibility profiles of lymphoma subtypes revealed by targeted cell free dna profiling M Mehrmohamadi, MS Esfahani, J Soo, F Scherer, JG Schroers-Martin, ... Blood 132, 672, 2018 | 5 | 2018 |
| A rare case of malignant transformation of oral lichen planus of the mandible J Soo, G Kokosis, M Ogilvie, DB Powers, DJ Rocke, D Erdmann Plastic and Reconstructive Surgery–Global Open 4 (12), e1070, 2016 | 5 | 2016 |
| Circulating tumor DNA in head and neck cancer: Early successes and future promise. J Soo, MC Jin, BM Beadle, FC Holsinger, A Finegersh Cancer (0008543X) 128 (11), 2022 | 4 | 2022 |
| Phased variants improve DLBCL minimal residual disease detection at the end of therapy. DM Kurtz, JJ Chabon, J Soo, L Co Ting Keh, S Alig, A Schultz, MC Jin, ... Journal of Clinical Oncology 39 (15_suppl), 7565-7565, 2021 | 4 | 2021 |
| Recurrent Crebbp mutations in follicular lymphoma appear localized to the committed B-cell lineage JG Schroers-Martin, J Soo, G Brisou, F Scherer, DM Kurtz, B Sworder, ... Blood 136, 30-31, 2020 | 4 | 2020 |
| Noninvasive detection of clinically relevant copy number alterations in diffuse large B-cell lymphoma. MC Jin, DM Kurtz, MS Esfahani, F Scherer, AFM Craig, J Soo, ... Journal of Clinical Oncology 35 (15_suppl), 7507-7507, 2017 | 4 | 2017 |
